Pacific Bio (PACB) Reports In-Line Q2 EPS

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $21.6 million versus the consensus estimate of $23.79 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT